Standout Papers

Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T C... 2007 2026 2013 2019 670
  1. Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies (2013)
    Gregory L. Beatty, Andrew R. Haas et al. Cancer Immunology Research
  2. CD8+ T-cell responses to adeno-associated virus capsid in humans (2007)
    Federico Mingozzi, Marcela V. Maus et al. Nature Medicine
  3. Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery (2018)
    Li Tang, Yiran Zheng et al. Nature Biotechnology
  4. Recent advances and discoveries in the mechanisms and functions of CAR T cells (2021)
    Rebecca C. Larson, Marcela V. Maus Nature reviews. Cancer
  5. Antibody-modified T cells: CARs take the front seat for hematologic malignancies (2014)
    Marcela V. Maus, Stephan A. Grupp et al. Blood
  6. T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans (2013)
    Marcela V. Maus, Andrew R. Haas et al. Cancer Immunology Research
  7. Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication (2018)
    Christopher C. Kloss, Ji‐Hyun Lee et al. Molecular Therapy
  8. Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing (2019)
    Benjamin P. Kleinstiver, Alexander A. Sousa et al. Nature Biotechnology
  9. Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma (2015)
    Alfred L. Garfall, Marcela V. Maus et al. New England Journal of Medicine
  10. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity (2019)
    Bryan D. Choi, Xiaoling Yu et al. Nature Biotechnology
  11. The Emerging Landscape of Immune Cell Therapies (2020)
    Evan W. Weber, Marcela V. Maus et al. Cell
  12. Ibrutinib treatment improves T cell number and function in CLL patients (2017)
    Meixiao Long, Kyle A. Beckwith et al. Journal of Clinical Investigation
  13. CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours (2022)
    Rebecca C. Larson, Michael C. Kann et al. Nature
  14. Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma (2024)
    Bryan D. Choi, Elizabeth R. Gerstner et al. New England Journal of Medicine
  15. CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells (2021)
    Karl Petri, Weiting Zhang et al. Nature Biotechnology
  16. Unanswered questions following reports of secondary malignancies after CAR-T cell therapy (2024)
    Bruce L. Levine, Marcelo C. Pasquini et al. Nature Medicine
  17. CAR T Cells and T-Cell Therapies for Cancer (2024)
    Jennifer N. Brudno, Marcela V. Maus et al. JAMA

Immediate Impact

20 by Nobel laureates 38 from Science/Nature 148 standout
Sub-graph 1 of 15

Citing Papers

Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
4 intermediate papers

Works of Marcela V. Maus being referenced

Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
2021
Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment
2017
and 1 more

Author Peers

Author Last Decade Papers Cites
Marcela V. Maus 9657 4734 4801 199 13.3k
Michael C. Milone 11138 5721 4395 134 15.1k
Isabelle Rivière 8876 4211 4079 156 11.8k
Simon F. Lacey 11529 4375 3810 157 14.5k
Michael Kalos 11484 5916 4825 94 15.2k
J. Joseph Melenhorst 10811 3936 3426 121 12.3k
Barbara Savoldo 13580 6394 4339 204 16.1k
Cameron J. Turtle 8393 3732 2937 162 11.4k
Renier J. Brentjens 14711 6602 5037 194 17.7k
Crystal L. Mackall 9385 4754 3450 146 12.4k
Stephen Gottschalk 9130 4584 2938 252 11.8k

All Works

Loading papers...

Rankless by CCL
2026